John S. Douglas

Emory University

Papers

2

Total Citations

81

H-Index

2

About

John S. Douglas is a pioneering figure in interventional cardiology, best known for advancing hybrid coronary revascularization (HCR) as a less invasive alternative to traditional bypass surgery. His research focuses on combining percutaneous coronary intervention (PCI) with minimally invasive surgical grafting to treat complex multi-vessel disease, particularly left main coronary stenosis. In a landmark 2011 feasibility study (20 citations), Douglas demonstrated that HCR could safely and effectively address left main stenosis, challenging the long-standing primacy of coronary artery bypass grafting (CABG). His subsequent 2013 work on clinical and angiographic outcomes (61 citations) provided robust evidence that HCR achieves excellent graft patency and low complication rates, solidifying its role in modern practice. With over 60 citations on his most influential paper alone, Douglas’s contributions have reshaped treatment paradigms, offering patients a tailored, less traumatic option. His work is a cornerstone for interventionalists and surgeons seeking to optimize revascularization strategies, blending technical innovation with rigorous outcomes research.

Research Focus

Key Achievements

2
H-Index
2
Papers
81
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Clinical and Angiographic Results After Hybrid Coronary Revascularization
61 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Emory University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago